Covered recipient · General Payments record
TARA GUNTER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$1,184.06
- Reported across 69 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $268.66 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $63.20 | 4 |
| ABBVIE INC. | $52.60 | 3 |
| PFIZER INC. | $47.50 | 3 |
| Novo Nordisk AS | $41.89 | 3 |
| Lilly USA, LLC | $31.63 | 2 |
| GlaxoSmithKline, LLC. | $17.76 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $14.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.49 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107265419 | CMS |
| ABBVIE INC. | $19.72 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107265421 | CMS |
| ABBVIE INC. | $14.39 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107265423 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.58 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104439817 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.18 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104376585 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.48 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105402725 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.96 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104737341 | CMS |
| GlaxoSmithKline, LLC. | $17.76 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116405281 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $14.08 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146766028 | CMS |
| Lilly USA, LLC | $14.81 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135894648 | CMS |
| Lilly USA, LLC | $16.82 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135960005 | CMS |
| Novo Nordisk Inc | $14.50 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100487871 | CMS |
| Novo Nordisk Inc | $13.41 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100348864 | CMS |
| Novo Nordisk Inc | $13.98 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100363947 | CMS |
| PFIZER INC. | $18.95 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131126468 | CMS |
| PFIZER INC. | $14.90 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131447074 | CMS |
| PFIZER INC. | $13.65 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131891531 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.